Naumann, J.A.; Argyris, P.P.; Carpenter, M.A.; Gupta, H.B.; Chen, Y.; Temiz, N.A.; Zhou, Y.; Durfee, C.; Proehl, J.; Koniar, B.L.; Conticello, S.G.; Largaespada, D.A.; Brown, W.L.; Aihara, H.; Vogel, R.I.; Harris, R.S. DNA Deamination Is Required for Human APOBEC3A-Driven Hepatocellular Carcinoma In Vivo. Int. J. Mol. Sci.2023, 24, 9305.
Naumann, J.A.; Argyris, P.P.; Carpenter, M.A.; Gupta, H.B.; Chen, Y.; Temiz, N.A.; Zhou, Y.; Durfee, C.; Proehl, J.; Koniar, B.L.; Conticello, S.G.; Largaespada, D.A.; Brown, W.L.; Aihara, H.; Vogel, R.I.; Harris, R.S. DNA Deamination Is Required for Human APOBEC3A-Driven Hepatocellular Carcinoma In Vivo. Int. J. Mol. Sci. 2023, 24, 9305.
Naumann, J.A.; Argyris, P.P.; Carpenter, M.A.; Gupta, H.B.; Chen, Y.; Temiz, N.A.; Zhou, Y.; Durfee, C.; Proehl, J.; Koniar, B.L.; Conticello, S.G.; Largaespada, D.A.; Brown, W.L.; Aihara, H.; Vogel, R.I.; Harris, R.S. DNA Deamination Is Required for Human APOBEC3A-Driven Hepatocellular Carcinoma In Vivo. Int. J. Mol. Sci.2023, 24, 9305.
Naumann, J.A.; Argyris, P.P.; Carpenter, M.A.; Gupta, H.B.; Chen, Y.; Temiz, N.A.; Zhou, Y.; Durfee, C.; Proehl, J.; Koniar, B.L.; Conticello, S.G.; Largaespada, D.A.; Brown, W.L.; Aihara, H.; Vogel, R.I.; Harris, R.S. DNA Deamination Is Required for Human APOBEC3A-Driven Hepatocellular Carcinoma In Vivo. Int. J. Mol. Sci. 2023, 24, 9305.
Abstract
Although the APOBEC3 family of single-stranded DNA cytosine deaminases are well-known as antiviral factors, these enzymes are rapidly gaining attention as prominent sources of mutation in cancer. APOBEC3 signature single base substitutions, C-to-T and C-to-G in TCA and TCT motifs, are evident in over 70% of human malignancies and dominate the mutational landscape of numerous individual tumors. Recent murine studies have established cause-and-effect relationships, with both human APOBEC3A and APOBEC3B proving capable of promoting tumor formation in vivo. Here, we investigate the molecular mechanism of APOBEC3A-driven tumor development using the murine Fah liver complementation and regeneration system. First, we show that APOBEC3A alone is capable of driving tumor development (without Tp53 knockdown as in prior studies). Second, we show that the catalytic glutamic acid residue of APOBEC3A (E72) is required for tumor formation. Third, we show that an APOBEC3A separation-of-function mutant with compromised DNA deamination activity and wildtype RNA editing activity is defective in promoting tumor formation. Collectively, these results indicate that APOBEC3A is a “master driver” that fuels tumor formation through a DNA deamination-dependent mechanism.
Keywords
APOBEC3A; carcinogenesis; DNA deamination; DNA mutation, hepatocellular carcinoma; molecular mechanism; RNA editing; tumorigenesis
Subject
Biology and Life Sciences, Biochemistry and Molecular Biology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.